FDA Inspection 1002967 — Atul Singhal, MD

Atul Singhal, MD — FEI 3013079349

The FDA completed an inspection of Atul Singhal, MD on Feb 21, 2017 in Mesquite, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 21, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Mesquite, TX (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.